Bøger i Cancer Biology and Medicine serien

It has been recognized for almost 200 years that certain families seem to inherit cancer. It is only in the past decade, however, that molecular genetics and epidemiology have combined to define the role of inheritance in cancer more clearly, and to identify some of the genes involved.

Most of the anti-cancer drugs in use today were discovered by happy accident rather than design, yet the rational design of better anti-cancer drugs remains a cherished goal, and one of the most important challenges facing medical science.

In the second part, we have asked researchers in different areas of biology applied to cancer to assess the present and likely future impact of their type of biology on cancer treatment and control.

There is no shonage of books on cancer. The quest to understand and control cancer is so absorbing that from time 10 time we really need to pause for a moment and try to take stock of the situation.

There is no shonage of books on cancer. The quest to understand and control cancer is so absorbing that from time 10 time we really need to pause for a moment and try to take stock of the situation.

Most of the anti-cancer drugs in use today were discovered by happy accident rather than design, yet the rational design of better anti-cancer drugs remains a cherished goal, and one of the most important challenges facing medical science.

1 Immunogenetics of nephritis.- 2 Introduction and regulation of autoimmune experimental glomerulonephritis.- 3 Molecular mechanisms of in situ immune complex formation in experimental membranous nephropathy.- 4 Immune complex handling in systemic lupus erythematosus.- 5 The membrane attack complex of complement in renal injury.- 6 Cell-mediated immunity in glomerulonephritis.- 7 Eicosanoids and cytokines in glomerular injury.- 8 Immunology of minimal-change nephropathy.- 9 IgA nephropathies and Henoch-Schonlein purpura.- 10 C3 nephritic factor and membranoproliferative glomerulonephritis.- 11 Anti-glomerular basement membrane disease.- 12 Autoimmunity in systemic vasculitis.- 13 Immunopathogenic mechanisms of interstitial nephritis.